Alvit LCS Pharma, based in Tel Aviv, specializes in the research and development of cannabis-based pharmaceutical products that are specifically designed to meet the needs of medical professionals. Established in 2014, Alvit has successfully developed a wide range of high-quality cannabis products, including tablets, sprays, and suppositories. Many of these products have already completed clinical trials and received approval in Israel.

What sets Alvit apart is its vertical integration, allowing the company to control every aspect of the cannabis drug development process, from cultivation to production, under strict EU-GMP conditions. In addition to its operations in Israel, Alvit has embarked on various international initiatives, such as Intelicanna, a publicly traded cannabis cultivation facility, and Mycolivia, a Medicinal Mushroom Company. Alvit Germany was also established to market and distribute Alvit's products in the German marketplace.

Moreover, Alvit has received a letter of intent in Malta to construct a state-of-the-art cultivation and production facility for medical cannabis intended for the European market. With its commitment to innovation and international expansion, Alvit is at the forefront of the cannabis pharmaceutical industry. Sign up to receive the latest news from Alvit LCS Pharma